IL-6 promotes the abnormal proliferation of cancer cells through the activation of the IL-6/STAT3 pathway, and the proliferation genes of cancer cells, such as Ras, Src, and cyclin D1, are the direct targets of STAT3 (82). Here, IL6 is linked to cancer.